PAR/DAN ratio | Suggested technique | Official USP method | ||||||
---|---|---|---|---|---|---|---|---|
Concentration taken (µg/mL) | Concentration found (µg/mL) | % Found | % Found | |||||
PAR | DAN | PAR | DAN | PAR | DAN | PAR | DAN | |
Dantrelax compound® 300PAR/25DAN | 120 | 10 | 117.648 | 9.865 | 98.04 | 98.65 | 98.04 | 100.75 |
150 | 12.5 | 152.325 | 12.606 | 101.94 | 100.85 | 101.94 | 98.69 | |
200 | 16.67 | 199.659 | 16.489 | 99.83 | 99.96 | 99.83 | 101.37 | |
Mean | Â | Â | Â | Â | 99.94 | 99.82 | 100.01 | 100.27 |
 ± S.D |  |  |  |  | 1.95 | 1.11 | 0.66 | 1.15 |
t test | Â | Â | Â | Â | 0.06 | 0.44 | (2.78)* | Â |
F test | Â | Â | Â | Â | 5.84 | 1.60 | (19.00)* | Â |